You need to enable JavaScript to run this app.
Recon: J&J Hit With $8B Damages in Risperdal Suit; FDA Approves Clinuvel’s Genetic Skin Disorder Drug
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher